Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
Displaying 1 - 10 of 457 Clinical Trials
ID/Name Source Type
16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients
NCT01948791 clinicaltrials.gov Clinical Trial
18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
NCT00103649 clinicaltrials.gov Clinical Trial
18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease
NCT02031198 clinicaltrials.gov Clinical Trial
221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
NCT02477800 clinicaltrials.gov Clinical Trial
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
NCT02484547 clinicaltrials.gov Clinical Trial
24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease
NCT02579252 clinicaltrials.gov Clinical Trial
3-month Study of MSDC-0160 Effects on Brain Glucose Utilization, Cognition & Safety in Subjects With Alzheimer's Disease
NCT01374438 clinicaltrials.gov Clinical Trial
4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease
NCT01039701 clinicaltrials.gov Clinical Trial
A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease
NCT01047579 clinicaltrials.gov Clinical Trial
A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA)
NCT00622713 clinicaltrials.gov Clinical Trial